Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for spasticity in MS
NCT00711646Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jun 2002
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in multiple sclerosis (MS), sponsored by Jazz Pharmaceuticals plc. Started Jun 2002; status: completed.
02
Drugs
cannabidiol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00711646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711646.